Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Imax (IMAX) downgraded to Hold from Buy Canaccord by analyst Aravinda Galappatthige, who cited weak box office trends, particularly in China. He believes the uncertainty around the China outlook and the less friendly slate of movies for 2019 will also be headwinds. 2. SQM (SQM) downgraded to Hold from Buy at Deutsche Bank by analyst Chris Terry, who said he is moving to the sidelines following the 9% share price increase over the past two weeks. He likes the fundamentals of the business but believes that the first half of the year "could still provide some moderate headwinds." 3. PayPal (PYPL) downgraded to Neutral from Buy at Buckingham. 4. Motif Bio (MTFB) downgraded to Neutral from Buy at H.C. Wainwright by analyst Raghuram Selvaraju, who said he is unsure whether the FDA would ever approve iclaprim, "regardless of what data Motif might be able to furnish." Further, he believes there is "considerable uncertainty regarding Motif's ability to fund such studies." 5. Allegion (ALLE) downgraded to In-Line from Outperform at Imperial Capital by analyst Jeff Kessler, who sees 7% potential upside following the company's Q4 results and 2019 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
click here.